Elizabeth Hall-Lipsy

Elizabeth Hall-Lipsy

Auto-generated profile, based on publicly available information

Elizabeth Hall-Lipsy

Associate Dean of Faculty and Academic Affairs, Associate Professor of Practice, R. Ken Coit College of Pharmacy, University of Arizona, Tucson, AZ

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2023 in JMIR Cancer
Verified
Journal Article
Open access
SVShannon Vaffis
Shannon Vaffis
SWSoluna Whaley
Soluna Whaley
David Rhys AxonDavid Rhys Axon
David Rhys Axon
EHElizabeth Hall-Lipsy
Elizabeth Hall-Lipsy
AHAna Lucia Hincapie
Ana Lucia Hincapie
TWTerri Warholak
Terri Warholak
Background: Cancer is increasingly being treated as a chronic disease rather than an acute one-time illness. Additionally, oral anticancer therapies, as opposed to intravenous chemotherapy, are now available for an increasing number of cancer indications. Mobile health (mHealth) apps for use on mobile devices (eg, smartphones or tablets) are designed to help patients with medication adherence, symptom tracking, and disease management. Several previous literature reviews have been conducted regarding mHealth apps for cancer. However, these studies did not address patient preferences for the features of cancer mHealth apps. Objective: The primary aim was to review the scientific literature that describes the features and functions of mHealth apps designed for cancer self-management. Methods: As the purpose of this review was to explore the depth and breadth of research on mHealth app features for cancer self-management, a scoping review methodology was adopted. Four databases were used for this review: PubMed/MEDLINE, Embase, CINAHL, and PsycINFO. Citation and reference searches were conducted for manuscripts meeting the inclusion criteria. A gray literature search was also conducted. Data extracted from manuscripts included author, title, publication date, study type, sampling type, cancer type, treatment, age of participants, features, availability (free or subscription), design input, and patient preferences. Finally, the features listed for each app were compared, highlighting similarities across platforms as well as features unique to each app. Results: After the removal of duplicates, 522 manuscripts remained for the title and abstract review, with 51 undergoing full-text review. A total of 7 manuscripts (referred to as studies hereafter) were included in the final scoping review. App features described in each study varied from 2 to 11, with a median of 4 features per app. The most reported feature was a symptom or side effect tracker, which was reported in 6 studies. Two apps specified the inclusion of patients and health care providers during the design, while 1 app noted that IT and communications experts provided design input. The utility of the apps for end users was measured in several ways, including acceptability (measuring the end users’ experience), usability (assessing the functionality and performance by observing real users completing tasks), or qualitative data (reports from end users collected from interviews or focus groups). Conclusions: This review explored the literature on cancer mHealth apps. Popular features within these mHealth apps include symptom trackers, cancer education, and medication trackers. However, these apps and features are often developed with little input from patients. Additionally, there is little information regarding patient preferences for the features of existing apps. While the number of cancer-related apps available for download continues to increase, further exploration of patient preferences for app features could result in apps that better meet patient disease self-management needs.

1 February 2018 in Journal of Managed Care & Specialty Pharmacy
Verified
Journal Article
Open access
MJMelissa Johnson
Melissa Johnson
RJRebecca Jastrzab
Rebecca Jastrzab
JTJared Tate
Jared Tate
KJKate Johnson
Kate Johnson
EHElizabeth Hall-Lipsy
Elizabeth Hall-Lipsy
TWTerri Warholak
Terri Warholak
BACKGROUND: Although the current methods of medication therapy management (MTM) delivery have demonstrably improved therapeutic, safety, economic, and humanistic health outcomes, patient- and prescriber-level barriers persist, limiting its reach and effectiveness. OBJECTIVE: To assess telephonic- and community-based clinical pharmacy services in improving health indicators for rural, underserved patients. METHODS: In 2014, an established MTM provider created a novel, collaborative pilot program with independent retail and community health center pharmacies to provide comprehensive, telephonic MTM services to rural Arizonans. This pilot program used a combined telephonic- and community-based pharmacist approach in the provision of MTM services for rural, underserved Arizona populations. Adults with diabetes mellitus and/or hypertension, seen by a prescriber or who filled prescriptions at a contracted, rural facility in 2014, were eligible to participate. Initial MTM telephonic consultations were conducted,...

16 October 2017 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
EHElizabeth Hall‐Lipsy
Elizabeth Hall‐Lipsy
SMSarah Malanga
Sarah Malanga
Scientists and academics are used to defending their theories, methods, and results in the classroom, at conferences, and in peer‐reviewed publications. But Pieter Cohen, an assistant professor at Harvard Medical School, learned that he had to defend his research in a defamation suit while reading a supplement industry trade publication (Robins, 2017). Cohen is known as a “dogged detective” for scrutinizing dietary supplements and for advocating for their stricter oversight by the US Food and Drug Administration (FDA).

1 October 2021 in Currents in Pharmacy Teaching and Learning
Verified
Journal Article
Closed access
SVShannon Vaffis
Shannon Vaffis
EAElizabeth J. Anderson
Elizabeth J. Anderson
RFRebekah M. Fettkeather
Rebekah M. Fettkeather
TWTerri Warholak
Terri Warholak
EHElizabeth Hall-Lipsy
Elizabeth Hall-Lipsy

1 September 2020 in Currents in Pharmacy Teaching and Learning
Verified
Journal Article
Closed access
RFRebekah M. Jackowski Fettkether
Rebekah M. Jackowski Fettkether
EHElizabeth A. Hall-Lipsy
Elizabeth A. Hall-Lipsy

16 November 2026 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
EHElizabeth Hall-Lipsy
Elizabeth Hall-Lipsy
BZBeth Zerr
Beth Zerr
KTKaren Tenace
Karen Tenace
AKAmy Kennedy
Amy Kennedy